Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Price History
|
Ratios
|
Insiders
Bullboard - Stock Discussion Forum
Innovation Pharmaceuticals Inc (EM)
IPIX
Healthcare
Biotechnology
Innovation Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective. Its lead drug candidate is Brilacidin, a therapeutic for the treatment of oral mucositis, inflammatory bowel disease, acute bacterial skin and skin structure infection, and COVID-19. The company has a license...
agreement with Alfasigma S.p.A.; and collaborative research agreement with Fox Chase Chemical Diversity Center, Inc. The company was formerly known as Cellceutix Corporation and changed its name to Innovation Pharmaceuticals Inc. in June 2017. Innovation Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Wakefield, Massachusetts.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (EXPM:IPIX)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
Next
(1)
•••
kaos12
X
Post by
kaos12
on Apr 23, 2018 8:46am
WAHOO! Mass production of Brilacidin with Evonik!
Innovation Pharmaceuticals Signs Drug Supply Contract with Evonik to Bulk Produce Commercial-Grade Brilacidin BEVERLY, MA – April 23, 2018 (GLOBE NEWSWIRE) Innovation Pharmaceuticals (OTCQB
...more
(0)
•••
Brito1
X
Post by
Brito1
on Apr 19, 2018 12:37pm
Quite Board
Bought more last week and this week...time will tell.
How Computing Everywhere Is Reshaping the Future of AI
posted May 09, 2026 9:00am by
Stockhouse Publishing Ltd.
-
|
As AI adoption accelerates, “compute everywhere” is emerging as a major infrastructure trend to watch. ...Inside the Trend
(1)
•••
kaos12
X
Comment by
kaos12
on Apr 17, 2018 1:41am
RE:Another 8-K today
Folks, read , What is an 8k and what does it mean, in this article and the second last paragraph of this article. Then let me know if you think there is manipulation of the stock price. This last 8k
...more
(0)
•••
TreeFrog
X
Post by
TreeFrog
on Apr 16, 2018 7:08pm
Another 8-K today
More good results from IPIX on the B-OM trials. Go to the website and check it out. Should be getting Phase 2B topline results any time now. The bashers on some of the US forums are really getting
...more
(0)
•••
aragon1959
X
Comment by
aragon1959
on Apr 16, 2018 11:58am
RE:RE:RE:RE:Folks still don’t know IPIX!
thx kaos another good news today everyone is waiting for some info. re cooperation with major pharma player, i guess. GLTA
(1)
•••
kaos12
X
Comment by
kaos12
on Apr 15, 2018 5:57pm
RE:RE:RE:Folks still don’t know IPIX!
Yeah, I think there is some manipulation with shorters, naked and otherwise. Over on iInvestorshangout.com there is a lady trader who really knows her stuff. Goes by “4thekids”. She demonstrates
...more
(0)
•••
aragon1959
X
Comment by
aragon1959
on Apr 12, 2018 7:29pm
RE:RE:Folks still don’t know IPIX!
Kaos do you think such a low SP could be effect of manipulation by shorts ?? If yes, they will pay dearly and soon I am such a fun of IPIX and their Brilacidin platform in OM and IBD Wonder whats
...more
(0)
•••
aragon1959
X
Comment by
aragon1959
on Apr 11, 2018 1:35pm
RE:Folks still don’t know IPIX!
agree with you completely . I thing low SP is a pure manipulation. This company is the ONLY one who has good ,trial prooven drug preventing OM. I am still buying on dips. First news about cooperation
...more
(1)
•••
kaos12
X
Post by
kaos12
on Apr 11, 2018 9:11am
Folks still don’t know IPIX!
IPIX news the other day is blockbuster news! Read the dam release people! Also, Leo filed an 8k which may portend a partnership or buyout. The 8k is to show that IPIX backs up their
...more
(0)
•••
aragon1959
X
Comment by
aragon1959
on Jan 30, 2018 4:13pm
RE:Abnormal volume and price!
agree with you 100% Kaos I am waiting for FDA approval of Brilacidin for OM No standard of treatment in OM so they dont need phase III trial 1-10 bln $ market Exciting times GLTA
(1)
•••
kaos12
X
Post by
kaos12
on Jan 29, 2018 5:54pm
Abnormal volume and price!
This is what I’ve been waiting for. Today’s news will have to reprice IPIX now, it was outstanding. Have known of IPIX for a little while and just couldn’t figure out why it wasn’t moving.
...more
(0)
•••
Brito1
X
Comment by
Brito1
on Jan 22, 2018 12:42pm
RE:RE:RE:news ??
Happy new year to you also.
(0)
•••
aragon1959
X
Comment by
aragon1959
on Jan 06, 2018 4:32pm
RE:RE:news ??
Thx Brito Agree with you 100% this one will reward those who are long on this stock and very patient psoriasis trial results coming soon and IPIX is applying to FDA for Bic.. approval for OM Should be
...more
(0)
•••
Brito1
X
Comment by
Brito1
on Jan 05, 2018 12:42pm
RE:news ??
Sorry, been away. Good news over the last two weeks, unfortunately to be a shareholder in this company you must have limitless patience.
(0)
•••
aragon1959
X
Post by
aragon1959
on Dec 06, 2017 3:00pm
news ??
Brito what do you think is happening ?? OM trial results coming soon ??
Prev
1
2
3
4
5
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
Featured News Links
Desert Gold Advances Barani Gravity Plant Installation and Confirms Commissioning Target
AI Beyond the Data Center: The Rise of Computing Everywhere
Podcasts